Business Context and Reporting Period
Company: OptimizeRx Corporation (OPRX)
Filing Type: Form 8-K (Current Report)
Report Date: August 7, 2025
Reporting Period: Second Quarter ended June 30, 2025
Business Context: The filing serves as a notification that the company issued a press release announcing its financial results for the second quarter of 2025. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text acts as a cover document referencing a press release (Exhibit 99.1) but does not contain specific financial data. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific numerical comparisons or details regarding material changes versus the prior comparable period. It only confirms the announcement of Q2 2025 results.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release for details but contains no direct commentary, guidance, or outlook within the 8-K text itself.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 7, 2025) for actual revenue, profit, and cash flow figures.
- Verify the specific details of the second-quarter results and any year-over-year comparisons in the referenced press release.
- Check for any forward-looking statements or updated guidance contained within the press release.
- Confirm the company's liquidity position and debt levels as detailed in the full financial statements referenced by the press release.